IGNIR offers science-based advice and guidance on the health and environmental effects of man-made non-ionising radiation.  Its aim is to protect people and the environment from detrimental exposure to man-made EMF pollution, and comprises three functions:
To provide advice about appropriate safety levels for man-made electromagnetic exposure
To assess published guidelines on man-made electromagnetic exposure and make its own recommendations as to which are appropriate
Provide practical and reliable assessment guidelines for surveyors and building biologists.

IGNIR has developed a set of Guidelines for electromagnetic exposure based on the peer-reviewed EUROPAEM EMF Guidelines 2016.

https://www.degruyter.com/document/doi/10.1515/reveh-2016-0011/html

It has three guideline groupings:
Day (D)
Night (N)
Sensitive (S)

It covers three frequency ranges:

Extremely Low Frequency

(ELF)Very Low Frequency

(VLF)Radiofrequency (RF)

Electromagnetic (EM) hygiene and safety involves minimising exposure levels that can be toxic to the environment and human health. The guidelines set forth by EUROPAEM (European Academy on Environmental Medicine) were published under open access by the international journal Reviews on Environmental Health. Although at present there are no assured safe levels of man-made EM exposure, and studies continue to show harm to living systems at very small exposure values, IGNIR’s guidance aims to help achieve substantial reduction in EM exposure.

IGNIR’s Guidelines are aimed to also help protect sensitive groups such as children, the elderly, fetuses, pregnant women, those with co-morbidity, body metal work and people with Electromagnetic Hypersensitivity (EHS).

IGNIR’s latest independent guidelines on EMF exposure are available now to download and use.

https://www.emfsa.co.za/wp-content/uploads/2021/03/IGNIR-Guidelines-2021.pdf

Source: https://ignir.org/

Added note by EMFSA:

See our February 2021 newsletter under the heading “Millimeter Waves Will Not Penetrate The Skin” https://mailchi.mp/emfsa/news

The post Jan 2021: IGNIR publishes International Guidelines for electromagnetic exposure appeared first on EMFSA.

Abstract

Chromogranin A (CgA), which is a major protein in adrenal chromaffin cells and adrenergic neurons, is a clinically relevant endocrine and neuroendocrine tumor marker including pheochromocytomas, neuroblastomas, and related neurogenic tumors. In this study, we looked at the effect in humans of chronic daily exposure to a 50-Hz magnetic field. We examined in 15 men (38.0 ± 0.9 years) the effects of chronic daily exposure to a 50-Hz magnetic field for 1-20 yrs both at home and at work. EMDEX II dosimeters were used to record magnetic field all day long every 30 s. for 1 week. The weekly geometric mean of the individual exposures ranged from 0.1 to 2.6 μT. Blood samples were taken hourly between 20:00 h and 08:00 h. CgA patterns of exposed subjects were compared to age-matched controls. The results of exposed subjects were compared with those for 15 unexposed men who served as controls and whose individual exposure was ten times lower ranging from 0.004 to 0.092 μT. This work shows that in the control group the serum CgA levels exhibited a nighttime peak with a progressive decline of the serum concentrations and a nadir in the morning. Both the profile and the serum concentrations of CgA, a marker of neuroendocrine tumors and stress, did not appear to be impaired in the subjects chronically exposed over a long period (up to 20 yrs) to magnetic fields though a trend toward lower levels were found at the highest exposure (>0.3 μT). This does not rule out, however, that the potential deleterious risk of ELF-EMF on frail populations such as children and the elderly may be greater at low exposure and should hence be documented, at least for their residential exposure.

https://www.ncbi.nlm.nih.gov/pubmed/31682468

The post Evaluation in humans of ELF-EMF exposure on chromogranin A, a marker of neuroendocrine tumors and stress. appeared first on EMFSA.